Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON)

Institut fuer Frauengesundheit · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
breast-cancerbreast-neoplasms
breast cancer, breast neoplasms, breast cancer female, her2-positive breast cancer, ontruzant, trastuzumab, pertuzumab, neoadjuvant chemotherapy, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 979539
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.